Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119449
Filing Date
2024-11-14
Accepted
2024-11-14 21:52:50
Documents
1
Group Members
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.DECHENG CAPITAL GLOBAL HEALTHCARE FUND (MASTER), LPDECHENG CAPITAL GLOBAL HEALTHCARE GP, LLCDECHENG CAPITAL MANAGEMENT II (CAYMAN), LLCXIANGMIN CUI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427620d29_sc13ga.htm SC 13G/A 154051
  Complete submission text file 0001104659-24-119449.txt   156040
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Subject) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90237 | Film No.: 241465686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8066
Decheng Capital Management III (Cayman), LLC (Filed by) CIK: 0001747821 (see all company filings)

EIN.: 981423513 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A